Abstract
BackgroundsMore than 300,000 patients undergo dialysis treatment today in Japan. In these patients, malignant disease is the third leading cause of death (accounting for 9%) following congestive heart failure and infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have